Correlation Between Evolus and Alterola Biotech
Can any of the company-specific risk be diversified away by investing in both Evolus and Alterola Biotech at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Evolus and Alterola Biotech into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Evolus Inc and Alterola Biotech, you can compare the effects of market volatilities on Evolus and Alterola Biotech and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Evolus with a short position of Alterola Biotech. Check out your portfolio center. Please also check ongoing floating volatility patterns of Evolus and Alterola Biotech.
Diversification Opportunities for Evolus and Alterola Biotech
0.25 | Correlation Coefficient |
Modest diversification
The 3 months correlation between Evolus and Alterola is 0.25. Overlapping area represents the amount of risk that can be diversified away by holding Evolus Inc and Alterola Biotech in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Alterola Biotech and Evolus is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Evolus Inc are associated (or correlated) with Alterola Biotech. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Alterola Biotech has no effect on the direction of Evolus i.e., Evolus and Alterola Biotech go up and down completely randomly.
Pair Corralation between Evolus and Alterola Biotech
Given the investment horizon of 90 days Evolus Inc is expected to under-perform the Alterola Biotech. But the stock apears to be less risky and, when comparing its historical volatility, Evolus Inc is 3.39 times less risky than Alterola Biotech. The stock trades about -0.16 of its potential returns per unit of risk. The Alterola Biotech is currently generating about 0.06 of returns per unit of risk over similar time horizon. If you would invest 0.53 in Alterola Biotech on September 1, 2024 and sell it today you would lose (0.03) from holding Alterola Biotech or give up 5.66% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 95.45% |
| Values | Daily Returns |
Evolus Inc vs. Alterola Biotech
Performance |
| Timeline |
| Evolus Inc |
| Alterola Biotech |
Evolus and Alterola Biotech Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Evolus and Alterola Biotech
The main advantage of trading using opposite Evolus and Alterola Biotech positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Evolus position performs unexpectedly, Alterola Biotech can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Alterola Biotech will offset losses from the drop in Alterola Biotech's long position.| Evolus vs. Collegium Pharmaceutical | Evolus vs. Phibro Animal Health | Evolus vs. ANI Pharmaceuticals | Evolus vs. Procaps Group SA |
| Alterola Biotech vs. Holloman Energy Corp | Alterola Biotech vs. cbdMD Inc | Alterola Biotech vs. Evolus Inc | Alterola Biotech vs. CV Sciences |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Premium Stories module to follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.
Other Complementary Tools
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Commodity Directory Find actively traded commodities issued by global exchanges |